SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056273
Filing Date
2021-11-10
Accepted
2021-11-10 17:02:35
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-10q_20210930.htm   iXBRL 10-Q 2272041
2 EX-31.1 snse-ex311_6.htm EX-31.1 19291
3 EX-31.2 snse-ex312_7.htm EX-31.2 19604
4 EX-32.1 snse-ex321_8.htm EX-32.1 9557
  Complete submission text file 0001564590-21-056273.txt   7930472

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA snse-20210930.xsd EX-101.SCH 57406
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snse-20210930_cal.xml EX-101.CAL 51985
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20210930_def.xml EX-101.DEF 204089
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20210930_lab.xml EX-101.LAB 442950
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20210930_pre.xml EX-101.PRE 341762
10 EXTRACTED XBRL INSTANCE DOCUMENT snse-10q_20210930_htm.xml XML 1306205
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 211397653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences